Handling "Not Reportable" Data [Bioanalytics]

posted by AngusMcLean – USA, 2014-11-28 20:09 (3831 d 04:11 ago) – Posting: # 13954
Views: 13,808

it seems to me that the value > 400 WAS discordant with respect to the pharmacoknetic trend of the values prior to it. As such it can be repeated as a pharmacokinetic outlier according to an appropriate SOP. If the two new values for the duplicate repeats carried out are within 20% of each other then according to appropriate SOP then they would be averaged and report this value. The >400 values is rejected as a pharmcokinetic outlier. You need an SOP policy in place to follow and in the analytical report all repeats are Tabulated together with the reason for repeats and final values. This report will reference the Lab. SOPs for repeats

Angus

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
21 visitors (0 registered, 21 guests [including 5 identified bots]).
Forum time: 01:21 CEST (Europe/Vienna)

An expert is someone who knows some of the worst mistakes
that can be made in his subject,
and how to avoid them.    Werner Heisenberg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5